- Location
Heart Transplant
"-
The Second Patient Implanted with a Carmat Artificial Heart
Jan 22, 2015The second patient implanted with a Carmat artificial heart has gone home, opening the way for others enrolled in the French company’s clinical trial to receive the devices. Carmat designed its self-regulated, bioprosthetic heart as ...
Tags: electric system, heart, Health
-
Total Artificial Heart Might Be The Next Potential Medtech Goldmine
Sep 10, 2014It's too early to tell, but the total artificial heart might be the next potential medtech goldmine. Shares of artificial heart maker Carmat climbed nearly 20% in mid-day trading on September 5 amidst recently-confirmed rumors that the ...
Tags: Health, Medicine, Artificial hearts
-
CareDx Intends to Make an IPO of Common Stock with The Intent of Realizing $50 Million.
Jun 13, 2014CareDx. which two weeks ago entered into an agreement to acquire ImmuMetrix Inc., has announced that it intends to make an initial public offering (IPO) of common stock with the intent of realizing $50 million. Brisbane, CA–based ...
-
Infants and Children Who Undergo Heart Transplantation Are Experiencing Good Outcomes
Feb 8, 2014Infants and children who undergo heart transplantation are experiencing good outcomes after surgery and may expect to live beyond 15 years post-surgery with reasonable cardiac function and quality of life, according to a study released ...
Tags: Loma Linda, heart transplant, Copeland, post-surgery
-
More Than Half of Babies and Children Are Surviving Many Years
Feb 7, 2014More than half of babies and children who receive heart transplants are surviving many years, say the authors of a new study. Pediatric heart transplant patients are living 15 years and longer with good heart function, the scientists ...
Tags: kids, Heart Transplant, Kidney failure, health
-
The "Grinch" Effect May Be Curbing Survival Rates in Some Heart Transplant Patients
Jan 10, 2014HealthDay Reporter Latest Heart News Fitness in Teen Years Guards Against Heart Trouble Hispanic Women Unaware of Heart Disease Risks Tretten Approved for Genetic Clotting Disorder 'Stress Gene' Might Raise Odds for Heart Attack Warfarin ...
-
The Heart Will Contain a Norwegian Pressure Sensor
Dec 30, 2013France is going to test an artificial heart on patients. The heart will contain a Norwegian pressure sensor. The French company Carmat will now proceed with full-scale testing on patients. It could save the lives of people who have been ...
Tags: artificial heart, Norwegian pressure sensor, Carmat, heart transplant
-
Dick Cheney Received a Heart Transplant in 2012.
Dec 20, 2013Earlier this month, Dick Cheney stated that the medical device tax may have killed him if it were in effect in the decades he struggled against heart disease. The former vice president received a heart transplant in 2012. Cheney is ...
Tags: medical device, tax, heart transplant
-
150th Total Artificial Heart Implant in 2013 Has Been Reported by Syncardia Systems
Dec 12, 2013US-based SynCardia Systems has announced the implantation of the 150th SynCardia temporary total artificial heart in 2013. The 150th SynCardia temporary total artificial heart has been implanted on 26 November 2013. In 2012, a total of ...
Tags: Heart Implant, Syncardia Systems
-
Diaxonhit and XDx Entered Into a Memorandum of Agreement for The Exclusive License
Jun 13, 2013France-based specialty diagnostic solutions provider Diaxonhit and XDx in the US, have entered into a memorandum of agreement (MoU) for the exclusive license to market and perform AlloMap Molecular Expression Testing (AlloMap) in Europe. ...
Tags: Diaxonhit Partners, Market Allomap
-
Paragonix Thas Won Phase I SBIR Grant for Cardiac Transport System Development
Dec 18, 2012Paragonix Technologies has won Phase I small business innovation research (SBIR) grant from the the National Heart, Blood and Lung Institute for the pre-clinical development of its Paragonix Sherpa cardiac transport system. Single-use, ...
Tags: Paragonix, SBIR grant, pre-clinical development, cardiac transport system
-
First US Patient Has Been Treated by Cytori in Cell Therapy Heart Failure Trial
Oct 12, 2012Cytori Therapeutics has treated first US patient in the ATHENA trial using the company's cell therapy based on patient's own adipose-derived stem and regenerative cells (ADRCs). ADRCs are processed using the company's proprietary Celution ...